Research Focus

Former Employee. GRADUATE STAFF; NE Rotating Housestaff

Recent additions – View all

1. Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1-based therapy

   Journal Article

   Saab, K. R.; Mooradian, M. J.; Wang, D. Y.; Chon, J.; Xia, C. Y.; Bialczak, A.; Abbate, K. T.; Menzies, A. M.; Johnson, D. B.; Sullivan, R. J.; more...
   Cancer (2019)

   Fulltext@MSK | Save
2. Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who have received PD-1 based therapy

   Meeting Abstract

   Saab, K.; Mooradian, M.; Wang, D. Y.; Chon, J.; Xia, C. Y.; Bialczak, A.; Abbate, K.; Menzies, A. M.; Johnson, D. B.; Sullivan, R. J.; more...
   Journal of Clinical Oncology (2018)

   Fulltext@MSK | Save